Matinas BioPharma Holdings Inc
MTNB
$2.37-2.07%
End of day · as of Oct 17, 2026, 4:15 AM ET
Mkt cap
$5.59M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2023-09-30)
$1.10M
EPS (H1 2026)
$-0.51
Gross Margin (qtr ended 2023-09-30)
N/A
Profit Margin (qtr ended 2023-09-30)
-552.46%
Beta
1.62
Div yield
N/A
Sector
Healthcare
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Latest reported MTNB revenue for 2023-09-30 was $1.1M. Net income was -$6.1M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. MTNB currently screens at market cap $5.6M.
Use this MTNB research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MTNB income, balance, and cash tables.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company in the Healthcare sector.
Latest cached Matinas BioPharma Holdings Inc (MTNB) revenue for Sep 30, 2023 was $1.1M. Net income was -$6.1M. Statements: https://lician.com/financials/mtnb
Matinas BioPharma Holdings Inc (MTNB) market capitalization is $5.6M on the latest cached snapshot.
Matinas BioPharma Holdings Inc (MTNB) cached previous close $2.42; day range $2.37 – $2.48; volume 21,774. Session quote: https://lician.com/quote/mtnb
Matinas BioPharma Holdings Inc (MTNB) latest cached earnings event is "MTNB earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MTNB filing is 8-K · Sep 28, 2026. Filings: https://lician.com/sec/mtnb